Clinical Trials Logo

Feeding and Eating Disorders clinical trials

View clinical trials related to Feeding and Eating Disorders.

Filter by:
  • Active, not recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06286852 Active, not recruiting - Clinical trials for Feeding and Eating Disorders of Childhood

Italian Language Validation of The Eating Disorder Examination (EDE) - Child Version

Start date: November 1, 2022
Phase:
Study type: Observational

Although eating disorders often occur during or after puberty, it is likely that critical antecedent conditions can be established before adolescence. The Eating Disorder Examination has been adapted for children and is described by Bryant - Waugh, Cooper, Taylor and Lask (1996). The EDE is considered the gold standard of measures of eating disorder psychopathology (Wilson, 1993), and this adaptation, which allows its use with a younger age group, is a potentially important addition to the assessment of eating disorders in children. The latest version of EDE, the l7th edition, has now surpassed its predecessors. The aim of the study is to evaluate the psychometric properties of the Child vers ion EDE (chEDE) translated into Italian, in a sample of patients with eating disorder

NCT ID: NCT06246032 Active, not recruiting - Preterm Clinical Trials

Impact of Modified Feeding Protocol on Neonatal Outcomes

Start date: May 1, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare modified feeding protocol and current feeding protocol on neonatal outcomes in preterm infants who born with weight less than 2kg. The main questions it aims to answer are: - Is Modified feeding protocol will decrease the duration of parenteral nutrition and length of hospital stay? - Is Modified feeding protocol feasible, efficient, and safe in preterm infants? Participants will undergo the modified feeding protocol since birth until discharge.

NCT ID: NCT06013137 Active, not recruiting - Depression Clinical Trials

Chatbot for Depression, Anxiety, and Eating Disorders

Start date: March 11, 2024
Phase: N/A
Study type: Interventional

The research team would like to test how efficacious an artificial intelligence chatbot is in delivering supportive behavioral interventions in populations with anxiety, depression, or eating concerns.

NCT ID: NCT06001398 Active, not recruiting - Clinical trials for Pediatric Feeding Dysfunction, Acute

Parent Acceptance and Commitment Therapy (PACT) for Parents of Children With Pediatric Feeding Disorder

PACT
Start date: June 27, 2023
Phase: N/A
Study type: Interventional

This is a pilot study of randomized clinical trial of Parent Acceptance and Commitment Therapy (PACT) vs. an attention-control condition (placebo) for improving the mental health of parents of children with pediatric feeding disorder. The goal of this clinical trial is to compare two programs in parents of children with pediatric feeding disorders. The main question[s] it aims to answer are: - PACT will result in clinically meaningful reductions in Mental Health(MH) problems among parents of children with Pediatric Feed Disorder (PFD) - Identify factors that impact the feasibility of PACT delivery - Participants will asked to participate in one of two programs focused on parents of children with pediatric feeding disorders. - The participants will also be asked to complete a battery of questionnaires at four timepoints during the study. - The parents will be asked to video record a meal time twice during study. If there is a comparison group: Researchers will compare the PACT group with a control group to see if PACT will result in clinically meaningful change in parent stress and anxiety, and parent use of positive mealtime behaviors.

NCT ID: NCT05794763 Active, not recruiting - Eating Disorders Clinical Trials

The Body Project: Comparing the Effectiveness of an In-person and Virtually Delivered Intervention.

Start date: March 31, 2022
Phase: N/A
Study type: Interventional

This present study will compare the efficacy of in-person versus virtually-delivered Body Project groups. It will also evaluate whether this body acceptance class produces greater reductions in eating disorder risk factor symptoms (pursuit of the thin ideal, body dissatisfaction, dieting, dietary restraint, negative affect, eating disorder symptoms, and the future onset of eating disorders over a 3-month follow-up in this population. It will also evaluate the effectiveness of this body acceptance class's ability to impact social appearance anxiety, body compassion, and self-stigma surrounding attaining help.

NCT ID: NCT05780242 Active, not recruiting - COVID-19 Clinical Trials

Recrudescence of Eating Conduct Disorders and Covid-19

TCA-Covid19
Start date: July 12, 2022
Phase:
Study type: Observational

This qualitative study, combining psychiatric and anthropological perspectives, focused on the development and/or worsening of patients' eating disorders since Covid-19, as well as the experiences and perceptions of those around them - such as their family, teachers or staff. School and nursing staff. This multi-site approach will provide a multidimensional perspective on the experience of individuals and those around them, as well as a triangulation of data. The hypotheses to explain the increase in Eating Disorders (EDs) will be addressed through semi-structured interviews offered to study participants.

NCT ID: NCT05560529 Active, not recruiting - Clinical trials for Binge Eating Disorder

Dialectical Behavioral Therapy As A Therapeutic Tool In Patients With Binge Eating Disorder

Start date: March 15, 2023
Phase: N/A
Study type: Interventional

Binge eating disorder (BED) is one of the recently acknowledged eating disorders, with many theories underlying its pathology whether biological or psychological. From the biological perspective, changes in plasma ghrelin were hypothesized to have a major role in developing and maintaining the disorder, while from the psychopathological perspectives, abnormalities in emotion regulation were found in many patients. Since Dialectical Behavioral Therapy (DBT) is known to target emotion dysregulation, the main aim of this study is to assess the efficacy of DBT versus treatment as usual (TAU) in BED patients, and whether plasma ghrelin level will be affected after treatment in both arms.

NCT ID: NCT05389657 Active, not recruiting - Anorexia Nervosa Clinical Trials

Optimizing Provider Training in Eating Disorders (OPTED)

OPTED
Start date: July 14, 2022
Phase: N/A
Study type: Interventional

This is a randomized controlled trial for mental health clinicians comparing two methods of training in family-based treatment (FBT) for restrictive eating disorders.

NCT ID: NCT05140109 Active, not recruiting - Eating Disorders Clinical Trials

Trial on Three Eating Disorders Group Treatment

Start date: September 1, 2018
Phase: N/A
Study type: Interventional

This trial aims at comparing three group treatments designed for eating disorders: a Cognitive-dissonance, a Mindfulness and a Person-centered based programs. Women with eating disorders will be recruited and randomized to one of the three programs. Participants will complete a pretest, a posttest, a 3-months follow-up and a 1-year follow-up. This trial aims to compare the programs to analyze the specific dimensions upon which each program acts. The investigators therefore made hypotheses according to the programs' theory: participants in the Cognitive-dissonance based program should experience a greater decrease in eating disorders symptoms, thin-ideal internalization and body dissatisfaction and a greater improvement in quality of life than other participants. Participants in the Mindfulness-based program should show a greater improvement in negative affect and in equanimity than other participants. Participants in the Person-Centered based program should report a greater increase in congruence than other participants.

NCT ID: NCT05105308 Active, not recruiting - Clinical trials for Eating Disorders in Children

Chompions! A Treatment Study for Childhood Avoidant/Restrictive Food Intake Disorder (ARFID)

Start date: February 10, 2022
Phase: N/A
Study type: Interventional

Avoidant Restrictive Food Intake Disorder (ARFID) is a disorder that affects toddlers, children, adolescents, and adults. Individuals with ARFID are not able to consume an adequate amount or variety of food to a degree that it affects their mental and/or physical health. ARFID often begins in early childhood so it is important to treat children in early in life as possible to prevent any negative consequences of poor nutrition. There are currently no treatments for young children with ARFID. The investigators have developed two different study programs and the purpose of this study is to test them out and see if they help children with ARFID and to learn more about how these study programs work.